Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-blockers for Distal Ureteral Stones
NCT00451061Phase 4Unknown
- Sponsor
- Soroka University Medical Center
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of alfuzosin and tamsulosin in ureterolithiasis and Renal colic (3 arms), sponsored by Soroka University Medical Center. Primary endpoints: Frequency of stone expulsion at 4 weeks, Time to stone expulsion at 4 weeks and 1 more. Status: unknown.
02
Drugs
alfuzosintamsulosin
03
Conditions
ureterolithiasisRenal colic
Beyond the preview
Go deeper on NCT00451061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451061.